FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3132133099> ?p ?o ?g. }

• W3132133099 endingPage "1912" @default.
• W3132133099 startingPage "1900" @default.
• W3132133099 abstract "Because disease-associated microglia (DAM) and disease-associated astrocytes (DAA) are involved in the pathophysiology of Alzheimer's disease (AD), we systematically identified molecular networks between DAM and DAA to uncover novel therapeutic targets for AD. Specifically, we develop a network-based methodology that leverages single-cell/nucleus RNA sequencing data from both transgenic mouse models and AD patient brains, as well as drug-target network, metabolite-enzyme associations, the human protein–protein interactome, and large-scale longitudinal patient data. Through this approach, we find both common and unique gene network regulators between DAM (i.e., PAK1 , MAPK14 , and CSF1R ) and DAA (i.e., NFKB1 , FOS , and JUN ) that are significantly enriched by neuro-inflammatory pathways and well-known genetic variants (i.e., BIN1 ). We identify shared immune pathways between DAM and DAA, including Th17 cell differentiation and chemokine signaling. Last, integrative metabolite-enzyme network analyses suggest that fatty acids and amino acids may trigger molecular alterations in DAM and DAA. Combining network-based prediction and retrospective case-control observations with 7.2 million individuals, we identify that usage of fluticasone (an approved glucocorticoid receptor agonist) is significantly associated with a reduced incidence of AD (hazard ratio [HR] = 0.86, 95% confidence interval [CI] 0.83–0.89, P < 1.0 × 10 −8 ). Propensity score–stratified cohort studies reveal that usage of mometasone (a stronger glucocorticoid receptor agonist) is significantly associated with a decreased risk of AD (HR = 0.74, 95% CI 0.68–0.81, P < 1.0 × 10 −8 ) compared to fluticasone after adjusting age, gender, and disease comorbidities. In summary, we present a network-based, multimodal methodology for single-cell/nucleus genomics-informed drug discovery and have identified fluticasone and mometasone as potential treatments in AD." @default.
• W3132133099 created "2021-03-01" @default.
• W3132133099 creator A5004589257 @default.
• W3132133099 creator A5018664407 @default.
• W3132133099 creator A5021122269 @default.
• W3132133099 creator A5037796382 @default.
• W3132133099 creator A5041038506 @default.
• W3132133099 creator A5046596147 @default.
• W3132133099 creator A5050942622 @default.
• W3132133099 creator A5052130722 @default.
• W3132133099 creator A5060487287 @default.
• W3132133099 creator A5068679708 @default.
• W3132133099 creator A5070676250 @default.
• W3132133099 creator A5076330540 @default.
• W3132133099 creator A5076504705 @default.
• W3132133099 date "2021-02-24" @default.
• W3132133099 modified "2023-10-15" @default.
• W3132133099 title "Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's disease" @default.
• W3132133099 cites W1598272861 @default.
• W3132133099 cites W1973543655 @default.
• W3132133099 cites W1978661028 @default.
• W3132133099 cites W1998905522 @default.
• W3132133099 cites W2002181764 @default.
• W3132133099 cites W2019208824 @default.
• W3132133099 cites W2054875722 @default.
• W3132133099 cites W2064145055 @default.
• W3132133099 cites W2064919477 @default.
• W3132133099 cites W2070745672 @default.
• W3132133099 cites W2072185180 @default.
• W3132133099 cites W2094136860 @default.
• W3132133099 cites W2100533805 @default.
• W3132133099 cites W2121604817 @default.
• W3132133099 cites W2125115279 @default.
• W3132133099 cites W2139771806 @default.
• W3132133099 cites W2146249493 @default.
• W3132133099 cites W2151390802 @default.
• W3132133099 cites W2168877831 @default.
• W3132133099 cites W2178222994 @default.
• W3132133099 cites W2327237185 @default.
• W3132133099 cites W2345356016 @default.
• W3132133099 cites W2471513101 @default.
• W3132133099 cites W2528555846 @default.
• W3132133099 cites W2537679995 @default.
• W3132133099 cites W2559588208 @default.
• W3132133099 cites W2610933369 @default.
• W3132133099 cites W2621695716 @default.
• W3132133099 cites W2622807556 @default.
• W3132133099 cites W2739103089 @default.
• W3132133099 cites W2753403576 @default.
• W3132133099 cites W2755548425 @default.
• W3132133099 cites W2767683865 @default.
• W3132133099 cites W2776096008 @default.
• W3132133099 cites W2794162793 @default.
• W3132133099 cites W2808735182 @default.
• W3132133099 cites W2808916408 @default.
• W3132133099 cites W2888882816 @default.
• W3132133099 cites W2894696369 @default.
• W3132133099 cites W2896440310 @default.
• W3132133099 cites W2897424830 @default.
• W3132133099 cites W2901303766 @default.
• W3132133099 cites W2904045480 @default.
• W3132133099 cites W2922229918 @default.
• W3132133099 cites W2965506096 @default.
• W3132133099 cites W2967683178 @default.
• W3132133099 cites W2969948459 @default.
• W3132133099 cites W2991414673 @default.
• W3132133099 cites W2998795963 @default.
• W3132133099 cites W3002293416 @default.
• W3132133099 cites W3011072970 @default.
• W3132133099 cites W3013656646 @default.
• W3132133099 cites W3013780107 @default.
• W3132133099 cites W3014251530 @default.
• W3132133099 cites W3015964336 @default.
• W3132133099 cites W3018541302 @default.
• W3132133099 cites W3034035589 @default.
• W3132133099 cites W3041781301 @default.
• W3132133099 cites W3093674228 @default.
• W3132133099 cites W3118272853 @default.
• W3132133099 cites W3119455494 @default.
• W3132133099 doi "https://doi.org/10.1101/gr.272484.120" @default.
• W3132133099 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8494225" @default.
• W3132133099 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33627474" @default.
• W3132133099 hasPublicationYear "2021" @default.
• W3132133099 type Work @default.
• W3132133099 sameAs 3132133099 @default.
• W3132133099 citedByCount "37" @default.
• W3132133099 countsByYear W31321330992021 @default.
• W3132133099 countsByYear W31321330992022 @default.
• W3132133099 countsByYear W31321330992023 @default.
• W3132133099 crossrefType "journal-article" @default.
• W3132133099 hasAuthorship W3132133099A5004589257 @default.
• W3132133099 hasAuthorship W3132133099A5018664407 @default.
• W3132133099 hasAuthorship W3132133099A5021122269 @default.
• W3132133099 hasAuthorship W3132133099A5037796382 @default.
• W3132133099 hasAuthorship W3132133099A5041038506 @default.
• W3132133099 hasAuthorship W3132133099A5046596147 @default.
• W3132133099 hasAuthorship W3132133099A5050942622 @default.
• W3132133099 hasAuthorship W3132133099A5052130722 @default.

• next